ICU Medical, Inc.
ICUI Healthcare Medical Instruments & Supplies
ICU Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, down 6.33% from fiscal 2024.
- Revenue
- +4.37%
- EPS
- +864.3%
- Free cash flow
- +292.2%
- Total debt
- −12.3%
Quarter to September 2026, against a year earlier
Follow ICUI
Alert me
ICU Medical, Inc. (ICUI) P/S ratio
As of 5 November 2026, ICU Medical, Inc. (ICUI) trades at a P/S ratio of 1.9×. Over the past ten years it has ranged from 0.9× (November 2023) to 6.7× (March 2017); the current reading is higher than 32% of that period. That is below the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 3.5×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 1.6× | (0.83%) |
| FY2024 | 1.6× | 46.67% |
| FY2023 | 1.1× | (35.25%) |
| FY2022 | 1.7× | (56.25%) |
| FY2021 | 3.8× | 8.37% |
| FY2020 | 3.5× | 15.73% |
| FY2019 | 3.0× | (8.86%) |
| FY2018 | 3.3× | 2.01% |
| FY2017 | 3.3× | (47.73%) |
| FY2016 | 6.3× | 19.92% |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Sep 2026 | 1.8× | 8.34% |
| Jun 2026 | 1.7× | 14.44% |
| Mar 2026 | 1.5× | (5.88%) |
| Dec 2025 | 1.6× | 23.45% |
| 43 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| NVST Envista Holdings Corporation compare | 1.4× |
| MMED MiniMed Group, Inc. compare | 1.7× |
| ICUI ICU Medical, Inc. | 1.9× |
| STVN Stevanato Group S.p.A. compare | 2.5× |
| TFX Teleflex Incorporated compare | 2.9× |
| MMSI Merit Medical Systems, Inc. compare | 3.3× |
| WRBY Warby Parker Inc. compare | 3.5× |
| ATRC AtriCure, Inc. compare | 5.0× |
| PLSE Pulse Biosciences, Inc compare | 2,559× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 3.5× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on ICUI
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement